CAI
$31.11+1.30%
Caris Life Sciences Inc.Stock · HealthcareNasdaq Composite · 0.01% of ONEQRussell 3000 · 0.003% of IWVRussell 1000 · 0.003% of IWBUS Stock Market · 0.003% of VTI
CAI — Caris Life Sciences Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEEE
15.020.025.030.035.0010.0M$31.11—JunOctFebJunOct
2026-10-20
Price$31.11
MA20$30.11
MA50$27.39
Vol3.5M
Key stats#
Price data
- Price
- $31.11
- YTD price return
- +15.31%
- YTD total return
- +15.31%
- Next earnings
- Nov 4, 2026 · After close
- Market cap
- 8.8B
- Enterprise value
- 8.3B
- Shares outstanding
- 282.6M
- 52W low
- $14.19
- 52W high
- $33.13
- From 52W high
- -6.10%
- From 52W low
- +119.24%
- 52W range
- 89%
Volume
- Rel volume
- 0.76×
- 30D volume
- 4.6M
- 30D $ vol
- 136.7M
Fundamentals
- Sales (ttm)
- 989.6M
- Sales/share
- $3.50
- EPS (ttm)
- $0.37
- FCF (ttm)
- 124M
- FCF/share
- $0.44
- Book value/share
- $2.09
- Net margin
- 10.62%
- ROE
- 17.77%
- ROA
- 8.55%
- Debt / equity
- 0.66×
- Current ratio
- 5.53
Growth (CAGR, ttm) · 10Y
- Sales
- +85.45%+59.98%n/an/a
- Shares
- +0.49%n/an/an/a
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +84.55%n/an/an/a
- Book value/share
- +30.04%n/an/an/a
- Price
- -1.24%n/an/an/a
- Total return
- -1.24%n/an/an/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 84.8×
- Fwd P/E
- 82.2×
- P/S (ttm)
- 8.9×
- P/B (mrq)
- 14.9×
- P/FCF (ttm)
- 70.9×
- EV/EBITDA (fy)
- 47.8×
- EV/Sales (ttm)
- 8.4×
- FCF yield (ttm)
- 1.41%
- Buyback yield (realized, 1y)
- -0.49%
- Shareholder yield (realized, 1y)
- -0.49%
- Buyback yield (cash, ttm)
- 0.24%
- Shareholder yield (cash, ttm)
- 0.24%
Performance · price return · as of 2026-10-20#
1D
+1.30%
5D
+5.35%
1M
+3.77%
3M
+99.94%
YTD
+15.31%
1Y
-1.24%
5Y
—
Financial statements
Open full CAI financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
